Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_assertion description "[Moreover, dominant negative cross talk between ectopic wild-type p53 and recently identified dominant p53 mutants and splice variants of p63 and p73--which are frequently overexpressed in ovarian cancers--could seriously compromise the effectiveness of p53 gene therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_assertion evidence source_evidence_literature NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_assertion SIO_000772 12850192 NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_assertion wasDerivedFrom befree-20140225 NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_assertion wasGeneratedBy ECO_0000203 NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.
- befree-20140225 importedOn "2014-02-25" NP256148.RA9hR_x2usd4sfs1NX2xGFZWgSG9nW4RCDK4Kz8JvuJG0130_provenance.